Kurz gefasst
Fachartikel in der Zeitschrift JP Journal of Biostatistics, 2026. Verfasst von Fozia Ali M. Arishi und 2 weiteren Autor:innen.
Themen: Schlaganfall
Abstract (Originalsprache)
Neuroinflammation critically shapes stroke outcomes, yet therapies often fail due to the biphasic nature of cytokines. Tumor Necrosis Factor-alpha ( ), for instance, drives acute injury (0-24h) but later supports repair. To address this paradox, we developed an Ordinary Differential Equation (ODE)-based model capturing interactions among , Interleukin- ( ), Interleukin-6 (IL-6), Interleukin-10 (IL-10), and microglial states ( pro-inflammatory, anti-inflammatory). The model simulates immune dynamics and therapeutic modulation over time. Simulations identified two optimal intervention windows: early suppression of (0-24h) reduced -driven damage, while delayed IL-10 enhancement ( ) promoted -mediated repair. The biphasic role of IL-6 - pro-inflammatory acutely, reparative later - was reproduced and validated against cytokine kinetics from tMCAo mouse models A combined regimen of inhibition in the acute phase and twofold IL-10 enhancement in the subacute phase reduced infarct volume by in silico. Although assuming uniform cytokine distribution, the model offers a framework for phased, precision-guided immunomodulation. These findings highlight the critical importance of timing in stroke immunotherapy and demonstrate the value of computational modeling for optimizing cytokine-based interventions.
Zitieren
APA
Arishi, F. A. M., Rambely, A. S., & Razak, F. A. (2026). BASED THERAPY FOR STROKE. JP Journal of Biostatistics. https://doi.org/10.17654/0973514326004
Vancouver
Arishi FAM, Rambely AS, Razak FA. BASED THERAPY FOR STROKE. JP Journal of Biostatistics. 2026. doi:10.17654/0973514326004
BibTeX
@article{Arishi2026,
author = {Arishi, Fozia Ali M. and Rambely, Azmin Sham and Razak, Fatimah Abdul},
title = {BASED THERAPY FOR STROKE},
journal = {JP Journal of Biostatistics},
year = {2026},
doi = {10.17654/0973514326004}
}
EUVIMED